Annual report pursuant to Section 13 and 15(d)

Balance Sheet Account Details - Contingent Liabilities (Details)

v3.22.4
Balance Sheet Account Details - Contingent Liabilities (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Contingent Liability [Roll Forward]    
Commercial rights, beginning of period $ 3,707 $ 41,929
Payments 0 (50)
Fair Value Adjustment (194) (38,172)
Repurchases 0  
Commercial rights, end of period 3,513 3,707
Cydex    
Contingent Liability [Roll Forward]    
Commercial rights, beginning of period 349 507
Payments 0 (50)
Fair Value Adjustment (265) (108)
Repurchases 0  
Commercial rights, end of period 84 349
Metabasis    
Contingent Liability [Roll Forward]    
Commercial rights, beginning of period 3,358 3,822
Payments 0 0
Fair Value Adjustment 71 (464)
Repurchases 0  
Commercial rights, end of period 3,429 3,358
Pfenex    
Contingent Liability [Roll Forward]    
Commercial rights, beginning of period 0 37,600
Payments 0 0
Fair Value Adjustment 0 (37,600)
Repurchases 0  
Commercial rights, end of period $ 0 $ 0